Company registration number 08959466 (England and Wales)
DENTAL EXCELLENCE STUDIO LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
DENTAL EXCELLENCE STUDIO LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
DENTAL EXCELLENCE STUDIO LTD
BALANCE SHEET
AS AT
31 JULY 2025
31 July 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
4
-
0
-
0
Tangible assets
5
163,700
35,643
Current assets
Stocks
60,000
60,000
Debtors
6
5,681,602
3,570,553
Cash at bank and in hand
54,882
270,002
5,796,484
3,900,555
Creditors: amounts falling due within one year
7
(1,011,755)
(501,899)
Net current assets
4,784,729
3,398,656
Total assets less current liabilities
4,948,429
3,434,299
Creditors: amounts falling due after more than one year
8
(847,173)
(623,213)
Net assets
4,101,256
2,811,086
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
4,101,156
2,810,986
Total equity
4,101,256
2,811,086

The notes on pages 3 to 8 form part of these financial statements.

DENTAL EXCELLENCE STUDIO LTD
BALANCE SHEET (CONTINUED)
AS AT
31 JULY 2025
31 July 2025
- 2 -

For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 31 July 2026
Dr R Hughes
Director
Company registration number 08959466 (England and Wales)
DENTAL EXCELLENCE STUDIO LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
1
Accounting policies
Company information

Dental Excellence Studio Ltd is a private company limited by shares incorporated in England and Wales. The registered office is C/O Sedulo Liverpool Limited, 5th Floor, Walker House, Exchange Flags, Liverpool, United Kingdom, L2 3YL.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is measured at the fair value of the dental service fees received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Revenue is recognised when the services are complete.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

DENTAL EXCELLENCE STUDIO LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on cost
Fixtures and fittings
25% on cost
Computers
25% on cost
Motor vehicles
Over the length of the agreement

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

DENTAL EXCELLENCE STUDIO LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

DENTAL EXCELLENCE STUDIO LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 6 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
14
0
4
Intangible fixed assets
Goodwill
£
Cost
At 1 August 2024 and 31 July 2025
160,000
Amortisation and impairment
At 1 August 2024 and 31 July 2025
160,000
Carrying amount
At 31 July 2025
-
0
At 31 July 2024
-
0
5
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 August 2024
316,739
74,105
17,153
-
0
407,997
Additions
-
0
-
0
-
0
157,963
157,963
At 31 July 2025
316,739
74,105
17,153
157,963
565,960
Depreciation and impairment
At 1 August 2024
285,294
70,928
16,132
-
0
372,354
Depreciation charged in the year
11,986
2,522
1,021
14,377
29,906
At 31 July 2025
297,280
73,450
17,153
14,377
402,260
Carrying amount
At 31 July 2025
19,459
655
-
0
143,586
163,700
At 31 July 2024
31,445
3,177
1,021
-
0
35,643
DENTAL EXCELLENCE STUDIO LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 7 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
112,912
201,697
Amounts owed by group undertakings and undertakings in which the company has a participating interest
5,278,276
2,078,132
Other debtors
290,414
1,290,724
5,681,602
3,570,553
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
484,521
214,937
Trade creditors
35,483
57,147
Amounts owed to group undertakings and undertakings in which the company has a participating interest
140,208
141,858
Corporation tax
176,645
-
0
Other taxation and social security
22,774
31,445
Other creditors
152,124
56,512
1,011,755
501,899
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
713,437
359,403
Other creditors
133,736
263,810
847,173
623,213
9
Financial commitments, guarantees and contingent liabilities

The company has given guarantees in respect of the lease obligations of certain fellow group undertakings. The total future lease payments covered by these guarantees amount to approximately £425,300.

 

The directors consider that the likelihood of a liability arising under these guarantees is remote and, accordingly, no provision has been recognised in these financial statements.

10
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

DENTAL EXCELLENCE STUDIO LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
10
Related party transactions
(Continued)
- 8 -
Name of related party
Nature of relationship
Avant Garde Solutions Limited
Fellow group undertaking
Dental Excellence Labs Limited
Fellow group undertaking
Theo-Nova Group Limited
Parent
Description of
Income
Payments
transaction
2025
2024
2025
2024
£
£
£
£
Avant Garde Solutions Limited
Training
282,876
-
0
-
0
-
0
Dental Excellence Labs Limited
Lab recharge
-
0
-
0
240,000
-
0
Theo-Nova Group Limited
Rent
-
0
-
0
156,000
-
0

All transactions were made on normal commercial terms.

Balances with related parties

The terms of the loans are unsecured, interest free and repayable on demand. No guarantees have been given to or received from related parties, other than those disclosed in 9.

 

No provisions for doubtful debts have been recognised in respect of these balances.

Amounts owed by
Amounts owed to
related parties
related parties
2025
2024
2025
2024
£
£
£
£
Avant Garde Solutions Limited
1,419,675
525,563
-
0
-
0
De Chelsea Limited
37
-
-
0
-
0
De London Holdings Limited
-
-
0
132,842
-
0
Dental Excellence Academy Limited
-
0
-
0
140,208
141,858
Dental Excellence Labs Limited
578,408
595,360
-
0
-
0
Mediform London Limited
193,178
128,901
-
0
-
0
Theo Consultancy Limited
433,550
40,900
-
0
-
0
Theo-Nova Group Limited
2,846,643
2,078,132
-
0
-
0
Other information

The company has provided guarantees in respect of the lease obligations of certain fellow group undertakings. These guarantees are provided in the normal course of business and no charge is made for this service.

 

No amounts have been recognised in respect of these guarantees as the directors do not expect any liability to arise.

2025-07-312024-08-01falsefalsefalse31 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityDr R Hughes089594662024-08-012025-07-31089594662025-07-31089594662024-07-3108959466core:NetGoodwill2025-07-3108959466core:NetGoodwill2024-07-3108959466core:PlantMachinery2025-07-3108959466core:FurnitureFittings2025-07-3108959466core:ComputerEquipment2025-07-3108959466core:MotorVehicles2025-07-3108959466core:PlantMachinery2024-07-3108959466core:FurnitureFittings2024-07-3108959466core:ComputerEquipment2024-07-3108959466core:MotorVehicles2024-07-3108959466core:CurrentFinancialInstrumentscore:WithinOneYear2025-07-3108959466core:CurrentFinancialInstrumentscore:WithinOneYear2024-07-3108959466core:Non-currentFinancialInstrumentscore:AfterOneYear2025-07-3108959466core:Non-currentFinancialInstrumentscore:AfterOneYear2024-07-3108959466core:CurrentFinancialInstruments2025-07-3108959466core:CurrentFinancialInstruments2024-07-3108959466core:ShareCapital2025-07-3108959466core:ShareCapital2024-07-3108959466core:RetainedEarningsAccumulatedLosses2025-07-3108959466core:RetainedEarningsAccumulatedLosses2024-07-3108959466bus:Director12024-08-012025-07-3108959466core:Goodwill2024-08-012025-07-3108959466core:PlantMachinery2024-08-012025-07-3108959466core:FurnitureFittings2024-08-012025-07-3108959466core:ComputerEquipment2024-08-012025-07-3108959466core:MotorVehicles2024-08-012025-07-31089594662023-08-012024-07-3108959466core:NetGoodwill2024-07-3108959466core:PlantMachinery2024-07-3108959466core:FurnitureFittings2024-07-3108959466core:ComputerEquipment2024-07-3108959466core:MotorVehicles2024-07-31089594662024-07-3108959466core:Non-currentFinancialInstruments2025-07-3108959466core:Non-currentFinancialInstruments2024-07-3108959466core:OtherGroupMember12024-08-012025-07-3108959466core:OtherGroupMember2core:ManagementRechargesServices2024-08-012025-07-3108959466core:ParentEntitiescore:RentalExpenseTransactions2024-08-012025-07-3108959466core:OtherGroupMember32024-08-012025-07-3108959466core:OtherGroupMember22024-08-012025-07-3108959466core:OtherRelatedParties2024-08-012025-07-3108959466core:UltimateParent2024-08-012025-07-3108959466core:ParentEntities2024-08-012025-07-3108959466core:OtherGroupMember12023-08-012024-07-3108959466core:OtherGroupMember2core:ManagementRechargesServices2023-08-012024-07-3108959466core:ParentEntitiescore:RentalExpenseTransactions2023-08-012024-07-3108959466core:OtherGroupMember12025-07-3108959466core:OtherGroupMember12024-07-3108959466core:OtherRelatedParties2024-07-3108959466core:OtherGroupMember32025-07-3108959466core:OtherGroupMember32024-07-3108959466core:OtherGroupMember22025-07-3108959466core:OtherGroupMember22024-07-3108959466core:UltimateParent2025-07-3108959466core:UltimateParent2024-07-3108959466core:ParentEntities2025-07-3108959466core:ParentEntities2024-07-3108959466core:OtherRelatedParties2025-07-3108959466bus:PrivateLimitedCompanyLtd2024-08-012025-07-3108959466bus:SmallCompaniesRegimeForAccounts2024-08-012025-07-3108959466bus:FRS1022024-08-012025-07-3108959466bus:AuditExemptWithAccountantsReport2024-08-012025-07-3108959466bus:FullAccounts2024-08-012025-07-31xbrli:purexbrli:sharesiso4217:GBP